These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22407309)

  • 1. Regulatory forum opinion piece: blind reading of histopathology slides in general toxicology studies.
    Neef N; Nikula KJ; Francke-Carroll S; Boone L
    Toxicol Pathol; 2012 Jun; 40(4):697-9. PubMed ID: 22407309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory forum opinion piece*: pathology peer review--dilemmas of documentation.
    Kerlin RL; Schafer KA
    Toxicol Pathol; 2013; 41(7):1049-50. PubMed ID: 23960162
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory forum opinion piece: Peer review documentation and pathology data locking.
    Neef N
    Toxicol Pathol; 2014; 42(2):311-3. PubMed ID: 24357644
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory forum opinion piece: thresholds in toxicologic pathology.
    Long GG; Hardisty JF
    Toxicol Pathol; 2012 Oct; 40(7):1079-81. PubMed ID: 22585940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory forum opinion piece*: pathology peer review--to lock or not to lock, is that really the question?
    Engelhardt JA; Hardisty JF; Mann PC
    Toxicol Pathol; 2013; 41(7):1051-2. PubMed ID: 23960166
    [No Abstract]   [Full Text] [Related]  

  • 7. Reporting of toxicologic histopathology: contrasting approaches in diagnostic versus experimental practice.
    Holland T
    Toxicol Pathol; 2011 Feb; 39(2):418-21. PubMed ID: 21422265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the study pathologist.
    Weber K
    Toxicol Pathol; 2014 Jan; 42(1):276-7. PubMed ID: 24334675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory Forum Opinion Piece: Blinding and Binning in Histopathology Methods in the Biomarker Qualification Process.
    Rouse R
    Toxicol Pathol; 2015 Aug; 43(6):757-9. PubMed ID: 25755101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicologic Pathology Forum*: Commentary on "Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma".
    Patrick DJ; Troth SP
    Toxicol Pathol; 2019 Jul; 47(5):574-576. PubMed ID: 31303126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Forum Opinion Piece*: Dispelling Confusing Pathology Terminology: Recognition and Interpretation of Selected Rodent Renal Tubule Lesions.
    Seely JC; Frazier KS
    Toxicol Pathol; 2015 Jun; 43(4):457-63. PubMed ID: 25869578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicologic Pathology Forum*: Opinion on Considerations for the Use of Whole Slide Images in GLP Pathology Peer Review.
    Bradley A; Jacobsen M
    Toxicol Pathol; 2019 Feb; 47(2):100-107. PubMed ID: 30636543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Society of Toxicologic Pathology position paper on best practices on recovery studies: the role of the anatomic pathologist.
    Perry R; Farris G; Bienvenu JG; Dean C; Foley G; Mahrt C; Short B;
    Toxicol Pathol; 2013; 41(8):1159-69. PubMed ID: 23531793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the evaluation of pathology data in nonclinical safety biomarker qualification studies.
    Burkhardt JE; Pandher K; Solter PF; Troth SP; Boyce RW; Zabka TS; Ennulat D
    Toxicol Pathol; 2011 Dec; 39(7):1129-37. PubMed ID: 22116771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory forum.
    Foster JR
    Toxicol Pathol; 2009 Apr; 37(3):269. PubMed ID: 19380838
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the pathologist in GLP studies.
    Weber K; Hailey JR; Mann PC; Seaton M; Funk KA
    Toxicol Pathol; 2014 Jan; 42(1):275. PubMed ID: 24436040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicologic Pathology Forum*: Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma.
    Gopinath C; Mowat V
    Toxicol Pathol; 2019 Jul; 47(5):564-573. PubMed ID: 31291835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best practices guideline: toxicologic histopathology.
    Crissman JW; Goodman DG; Hildebrandt PK; Maronpot RR; Prater DA; Riley JH; Seaman WJ; Thake DC
    Toxicol Pathol; 2004; 32(1):126-31. PubMed ID: 14713558
    [No Abstract]   [Full Text] [Related]  

  • 20. Best practices for reporting pathology interpretations within GLP toxicology studies.
    Morton D; Kemp RK; Francke-Carroll S; Jensen K; McCartney J; Monticello TM; Perry R; Pulido O; Roome N; Schafer K; Sellers R; Snyder PW
    Toxicol Pathol; 2006; 34(6):806-9. PubMed ID: 17162539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.